-

NYSE to Commence Delisting Proceedings Against Babylon Holdings Limited (BBLN)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A ordinary shares of Babylon Holdings Limited (the “Company”) — ticker symbol BBLN — from the NYSE. Trading in the Company’s Class A ordinary shares will be suspended immediately.

On June 22, 2023, NYSE Regulation notified the Company of noncompliance with the continued listing standards in Sections 802.01B and 802.01C of the NYSE Listed Company Manual. On June 28, 2023, the Company informed the NYSE and made public disclosure that it did not intend to submit a business plan demonstrating its ability to return to compliance with continued listing standards within 18 months of the notice from the Exchange and did not have an intention to cure the price noncompliance within six months of the notice from the Exchange, as required by Sections 802.02 and 802.01C of the NYSE Listed Company Manual, respectively. NYSE Regulation has determined that the Company is no longer suitable for listing since the Company does not intend to undertake actions to cure its deficiencies and return to compliance with the continued listing standards in Sections 802.01B and 802.01C of the NYSE Listed Company Manual.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Class A ordinary shares upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Contacts

Company Contact:
Media
press@babylonhealth.com

Investors
investors@babylonhealth.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contact:
Media
press@babylonhealth.com

Investors
investors@babylonhealth.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. NYSE Regulation reached its decision to commence proceedings to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s...

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Vicarious Surgical Inc. (the “Company”) — ticker symbol RBOT — from the NYSE. Trading in the Company’s Class A common stock will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Class A common stock pursuant to Section 802.01B of the NYSE’s Listed Compan...

NYSE to Commence Delisting Proceedings Against Trinseo PLC (TSE)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares of Trinseo PLC (the “Company”) — ticker symbol TSE — from the NYSE. Trading in the Company’s ordinary shares will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s ordinary shares pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company...
Back to Newsroom